• Outset Medical Inc OM.OQ OM.O is expected to show a fall in quarterly revenue when it reports results on February 19 for the period ending December 31 2024

• The San Jose California-based company is expected to report a 6.7% decrease in revenue to $28.474 million from $30.51 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Outset Medical Inc is for a loss of 41 cents per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Outset Medical Inc is $3.00​, above​ its last closing price of $0.90. ​​​

The company's guidance on August 7 2024 for the period ended December 31 was for gross profit margin between 34% and 36%.

Previous quarterly performance (using preferred earnings measure in US dollars). ​

This summary was machine generated February 17 at 21:59 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)